美诺华：子公司非布司他片获得药品注册证书

Core Viewpoint - Menova announced that its wholly-owned subsidiary, Ningbo Menova Tiankang Pharmaceutical Co., Ltd., has recently received the drug registration certificate for Febuxostat tablets from the National Medical Products Administration [1] Group 1 - Menova's subsidiary has been granted approval for Febuxostat tablets, indicating a significant regulatory milestone [1]